News EMA CHMP Recommends Twelve New Medicines for Approval at July 2026 Meeting pharminent July 24, 2026
News Lilly’s Retatrutide Hits 22.6% Weight Loss in Phase 3, But Cardiovascular Benefit Remains Elusive pharminent July 23, 2026
News Arrowhead’s Plozasiran Cuts Triglycerides Roughly 80% in Two Phase 3 Trials pharminent July 22, 2026
News Samsung Biologics Acquires Swiss CDMO PolyPeptide in $1.81bn All-Cash Deal pharminent July 20, 2026
News Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra pharminent July 16, 2026
News J&J Beats Q2 Estimates, Raises Full-Year Guidance on Innovative Medicine Strength pharminent July 15, 2026
News Biogen’s Tau-Targeting Alzheimer’s Data Show Promise — and Raise Questions pharminent July 14, 2026
News Roche Scraps Two Ionis-Partnered Huntington’s Studies After Tominersen Failure pharminent July 10, 2026
News Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK pharminent July 8, 2026
News BioNTech Held Buyer Talks Over Four German Sites Set to Close, Handelsblatt Reports pharminent July 3, 2026
News Roche’s Divarasib Beats Amgen and BMS Head-to-Head in Phase 3 KRAS Lung Cancer Trial pharminent July 2, 2026
News Ipsen Acquires Memo Therapeutics for Up to €700M in Second Deal in Three Days pharminent July 1, 2026
News NEJM Retracts Pivotal Tavneos Paper as Amgen’s FDA Data-Integrity Fight Deepens pharminent June 30, 2026
News Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease pharminent June 29, 2026
